ALBIOMIN

This brand name is authorized in Austria, Brazil, Cyprus, Hong Kong SAR China, Israel, Malta, Poland, Romania, Spain, Tunisia, Turkey.

Active ingredients

The drug ALBIOMIN contains one active pharmaceutical ingredient (API):

1	Albumin UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)
	Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.
	Read more about Albumin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05AA01	Albumin	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	524614020001704, 524614020001804
ES	Centro de información online de medicamentos de la AEMPS	71446
HK	Department of Health Drug Office	66288, 66289
IL	מִשְׂרַד הַבְּרִיאוּת	6891
MT	Medicines Authority	MA008/00202, MA008/00203
PL	Rejestru Produktów Leczniczych	100212390
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53930001, W53930002, W53931001
TN	Direction de la Pharmacie et du Médicament	8153091H, 8153092H
TR	İlaç ve Tıbbi Cihaz Kurumu	8682109319805, 8682109319812